Filters: Author is Silverman, Daniel H S [Clear All Filters]
Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment.. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. 4(4):283-93.. 2002.
Clinical Value of Neuroimaging in the Diagnosis of Dementia. Sensitivity and Specificity of Regional Cerebral Metabolic and Other Parameters for Early Identification of Alzheimer's Disease.. Clinical positron imaging : official journal of the Institute for Clinical P.E.T. 2(3):119-130.. 1999.
Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study.. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 16(12):999-1009.. 2008.
Effects of a 14-day healthy longevity lifestyle program on cognition and brain function.. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 14(6):538-45.. 2006.
Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 43(2):253-66.. 2002.
Functional imaging as a window to dementia: corticobasal degeneration.. The Journal of neuropsychiatry and clinical neurosciences. 16(4):393-9.. 2004.
Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder.. Biological psychiatry. 69(4):374-80.. 2011.
Positron emission tomography scans obtained for the evaluation of cognitive dysfunction.. Seminars in nuclear medicine. 38(4):251-61.. 2008.
Prompt identification of Alzheimer's disease with brain PET imaging of a woman with multiple previous diagnoses of other neuropsychiatric conditions.. The American journal of psychiatry. 159(9):1482-8.. 2002.